{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:14:31Z","timestamp":1759335271917},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T00:00:00Z","timestamp":1570147200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Women's Dermatology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ijwd.2019.09.007","type":"journal-article","created":{"date-parts":[[2019,10,26]],"date-time":"2019-10-26T21:40:22Z","timestamp":1572126022000},"page":"335-339","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Is substance use disorder more prevalent in patients with hidradenitis suppurativa?"],"prefix":"10.1097","volume":"5","author":[{"given":"Paola C.","family":"Aldana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcia S.","family":"Driscoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"4","key":"10.1016\/j.ijwd.2019.09.007_b0005","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1370\/afm.1139","article-title":"Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population","volume":"8","author":"Arroll","year":"2010","journal-title":"Ann Fam Med"},{"issue":"1","key":"10.1016\/j.ijwd.2019.09.007_b0010","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.det.2015.07.003","article-title":"The handicap of hidradenitis suppurativa","volume":"34","author":"Deckers","year":"2016","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.ijwd.2019.09.007_b0015","doi-asserted-by":"crossref","unstructured":"Enamandram M, Rathmell JP, Kimball AB. Chronic pain management in dermatology: pharmacotherapy and therapeutic monitoring with opioid analgesia. J Am Acad Dermatol 2015;73(4):575\u201382; quiz 583\u20134.","DOI":"10.1016\/j.jaad.2014.11.038"},{"issue":"3","key":"10.1016\/j.ijwd.2019.09.007_b0020","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2340\/00015555-1082","article-title":"Psychosocial impact of hidradenitis suppurativa: a qualitative study","volume":"91","author":"Esmann","year":"2011","journal-title":"Acta Derm Venereol"},{"issue":"3","key":"10.1016\/j.ijwd.2019.09.007_b0025","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jaad.2018.02.053","article-title":"Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: a population-based analysis in the United States","volume":"79","author":"Garg","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"5 Suppl 1","key":"10.1016\/j.ijwd.2019.09.007_b0030","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jaad.2015.07.046","article-title":"Pain management in patients with hidradenitis suppurativa","volume":"73","author":"Horv\u00e1th","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.ijwd.2019.09.007_b0035","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jid.2017.06.020","article-title":"Patients with hidradenitis suppurativa have a high psychiatric disease burden: a Finnish nationwide registry study","volume":"138","author":"Huilaja","year":"2018","journal-title":"J Invest Dermatol"},{"issue":"2","key":"10.1016\/j.ijwd.2019.09.007_b0040","first-page":"275","article-title":"High prevalence of cannabis use among patients with hidradenitis suppurativa: results from the VERADDICT survey","volume":"181","author":"Lesort","year":"2019","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.ijwd.2019.09.007_b0045","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1087-0024.2004.09113.x","article-title":"10 years experience of the Dermatology Life Quality Index (DLQI)","volume":"9","author":"Lewis","year":"2004","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.ijwd.2019.09.007_b0050","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.drugalcdep.2018.03.041","article-title":"Understanding emerging forms of cannabis use through an online cannabis community: an analysis of relative post volume and subjective highness ratings","volume":"188","author":"Meacham","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.ijwd.2019.09.007_b0055","unstructured":"National Conference of State Legislators. State medical marijuana laws [Internet]. 2019 [cited 2019 May 18]. Available from: http:\/\/www.ncsl.org\/research\/health\/state-medical-marijuana-laws.aspx."},{"key":"10.1016\/j.ijwd.2019.09.007_b0060","unstructured":"National Institute on Drug Abuse website. Marijuana [Internet]. 2019 [cited 2019 May 27]. Available from: https:\/\/www.drugabuse.gov\/node\/pdf\/1380\/marijuana."},{"issue":"4","key":"10.1016\/j.ijwd.2019.09.007_b0065","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1468-3083.2012.04468.x","article-title":"Depression in patients with hidradenitis suppurativa","volume":"27","author":"Onderdijk","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.ijwd.2019.09.007_b0070","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/bjd.17416","article-title":"Association between hidradenitis suppurativa and hospitalization for psychiatric disorders: a cross-sectional analysis of the National Inpatient Sample","volume":"181","author":"Patel","year":"2019","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.ijwd.2019.09.007_b0075","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/DSS.0000000000001693","article-title":"Pain management in patients with hidradenitis suppurativa requiring surgery","volume":"45","author":"Puza","year":"2019","journal-title":"Dermatol Surg"},{"issue":"7","key":"10.1016\/j.ijwd.2019.09.007_b0080","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/add.14523","article-title":"Why Uruguay legalized marijuana? The open window of public insecurity","volume":"114","author":"Queirolo","year":"2019","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.ijwd.2019.09.007_b0085","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/bjd.16998","article-title":"Prevalence of patients with self-reported hidradenitis suppurativa in a cohort of Danish blood donors: a cross-sectional study","volume":"180","author":"Theut Riis","year":"2019","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.ijwd.2019.09.007_b0090","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2340\/00015555-2308","article-title":"Pain in hidradenitis suppurativa: a pilot study","volume":"96","author":"Ring","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.ijwd.2019.09.007_b0095","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/bjd.14266","article-title":"Self-reported pain management in hidradenitis suppurativa","volume":"174","author":"Ring","year":"2016","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.ijwd.2019.09.007_b0100","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","article-title":"Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies","volume":"59","author":"Revuz","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.ijwd.2019.09.007_b0105","first-page":"1273","article-title":"Knowledge, attitudes, and perceptions of cannabinoids in the dermatology community","volume":"17","author":"Robinson","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.ijwd.2019.09.007_b0110","series-title":"Comprehensive treatment of chronic pain by medical, interventional, and integrative approaches","article-title":"Role of cannabinoids in pain management","author":"Russo","year":"2013"},{"issue":"20","key":"10.1016\/j.ijwd.2019.09.007_b0115","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1001\/jama.2017.16691","article-title":"Hidradenitis suppurativa: advances in diagnosis and treatment","volume":"318","author":"Saunte","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ijwd.2019.09.007_b0120","doi-asserted-by":"crossref","first-page":"20616","DOI":"10.5070\/D31911020616","article-title":"Treatment of hidradenitis suppurativa associated pain with nonsteroidal anti-inflammatory drugs, acetaminophen, celecoxib, gabapentin, pegabalin, duloxetine, and venlafaxine","volume":"19","author":"Scheinfeld","year":"2013","journal-title":"Dermatol Online J"},{"issue":"4","key":"10.1016\/j.ijwd.2019.09.007_b0125","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/bjd.17249","article-title":"The epidemiology of hidradenitis suppurativa: what do we know?","volume":"180","author":"Shalom","year":"2019","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.ijwd.2019.09.007_b0130","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/ijd.13798","article-title":"Longitudinal observational study of hidradenitis suppurativa: impact of surgical intervention with adjunctive biologic therapy","volume":"57","author":"Shanmugam","year":"2018","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.ijwd.2019.09.007_b0135","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.jaad.2014.09.012","article-title":"Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis","volume":"71","author":"Shlyankevich","year":"2014","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.ijwd.2019.09.007_b0140","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/AJP.0b013e3181ceb80c","article-title":"Painful hidradenitis suppurativa","volume":"26","author":"Smith","year":"2010","journal-title":"Clin J Pain"},{"issue":"4","key":"10.1016\/j.ijwd.2019.09.007_b0145","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/0091450916667081","article-title":"Marijuana policy opinions in Washington state since legalization: would voters vote the same way?","volume":"43","author":"Subbaraman","year":"2016","journal-title":"Contemp Drug Probl"},{"issue":"5","key":"10.1016\/j.ijwd.2019.09.007_b0150","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jpain.2016.11.009","article-title":"Analgesic effects of alcohol: a systematic review and meta-analysis of controlled experimental studies in healthy participants","volume":"18","author":"Thompson","year":"2017","journal-title":"J Pain"},{"issue":"4","key":"10.1016\/j.ijwd.2019.09.007_b0155","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1046\/j.1365-2133.2001.04137.x","article-title":"Morbidity in patients with hidradenitis suppurativa","volume":"144","author":"von der Werth","year":"2001","journal-title":"Br J Dermatol"}],"container-title":["International Journal of Women's Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647519301066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352647519301066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,10,2]],"date-time":"2022-10-02T19:25:32Z","timestamp":1664738732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352647519301066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S2352647519301066"],"URL":"https:\/\/doi.org\/10.1016\/j.ijwd.2019.09.007","relation":{},"ISSN":["2352-6475"],"issn-type":[{"value":"2352-6475","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is substance use disorder more prevalent in patients with hidradenitis suppurativa?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Women's Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijwd.2019.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of Women's Dermatologic Society.","name":"copyright","label":"Copyright"}]}}